Best Anabolic Steroids

Press Enter to search the full catalog.

US Domestic discreet shipping
Third-party batch tested
HPLC & MS verified purity
Trusted Anabolic Manufacturers Only
US Domestic discreet shipping
Third-party batch tested
HPLC & MS verified purity
Trusted Anabolic Manufacturers Only
Back to all products
Sermorelin 2-10 mg Vials - Generic Peptides Sermorelin 2-10 mg Vials - Generic Peptides Sermorelin 2-10 mg Vials - Generic Peptides

Generic Peptides

Sermorelin 2-10 mg Vials - Generic Peptides

Injection · 2 mg · vial

In stock · ships within 24h Out of stock Ships from International · U.S Domestic
CompoundSermorelin
ClassGHRH analogue
Half-lifeMinutes, human value unset
DetectionWADA S2, prohibited
Liver toxicityLow
Water retentionLow
Three freeze-dried vials of a fragment of growth hormone releasing hormone, written in the literature as GHRH(1-29) and once sold in pharmacies as Geref before that product was withdrawn. Its activity is measured in minutes, not hours, which forces a daily injection and makes a pulse the only thing it can produce. A human half-life has never been settled: the 6.2 minute figure comes from an intravenous study in rats, while vendor texts quote 10 to 20 minutes.
Strength

Not available in this combination

Shipping

Not available in this combination

Sermorelin 2-10 mg Vials - Generic Peptides
Order Now, Ships Today
$34.00
2
Quality First

All products are manufactured under strict quality standards and independently tested before release. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.

Product Overview

Sermorelin is the first 29 amino acids of growth hormone releasing hormone, a fragment rather than a copy of the whole hormone. It tells the pituitary to release its own growth hormone in the natural pulse pattern, which is why it belongs to the GHRH side of peptide research and pairs so often with a ghrelin-side partner.

Generic Peptides lists it as 2 mg, 5 mg and 10 mg lyophilised vials, labelled Sermoreline on the pack. The pharmacy story is worth knowing: an injectable version existed as Geref, used for diagnosis and for growth hormone deficiency, and it was discontinued. Everything on sale now, including these vials, is research material. CJC-1295 DAC is a modified GHRH analogue built to solve the same problem this peptide suffers from.

That problem is duration. The parent molecule GHRH(1-29)-amide showed a 6.2 minute half-life in an intravenous rat study, and vendor descriptions put it at 10 to 20 minutes in general use; a settled human figure does not exist in the sources. Growth hormone release therefore arrives as a brief impulse and vanishes, so a single injection cannot cover a day. Rival ghrelin-side compounds such as Ipamorelin need several shots a day for the same reason.

Dosage Protocol

No human dose is confirmed. The amounts below come from vendor grading, and the sources checked describe no female protocol at all.

Item Figure Basis
Base research amount Vendor-defined starting figure Not a clinical dose
Higher band 400-500 mcg daily Vendor gradation only
Frequency Every day, usually before sleep Very short activity makes one shot insufficient
Block length 12-16 weeks, then 4-6 weeks off Vendor protocol
Female No confirmed protocol Nothing found in the sources checked

Mixing follows the usual rule: bacteriostatic water added down the side of the vial, never shaken. One millilitre in the 5 mg vial gives 5 mg per millilitre, and two millilitres gives 2.5 mg per millilitre, so the same vial can be set up strong or gentle depending on the volume a user finds easiest to measure. The 2 mg vial at 1 ml and the 10 mg vial at 4 ml both land on the 2.5 mg per millilitre of the middle option, which makes any of the three usable at a familiar strength.

Suggested Protocols

GHRH and ghrelin peptides are treated as two halves of one release, since the receptors are distinct and the combined result exceeds either alone. The pairing below reflects that research logic.

Daily pairing
Sermorelin - GHRH side + GHRP-2 - ghrelin side
Two receptors, one hormone; both partners are short-acting, so the injections share an evening window
GHRH comparisons
All three ask the same receptor; they differ in how long the signal survives, and only one has clinical trial data behind it

Other shelf entries serve as context: GHRP-6 for the appetite-heavy ghrelin option, Hexarelin for the strongest and fastest-fading of that group, and Somatropin for supplied hormone rather than a signal. Switching to a long-acting partner changes the rhythm of the whole protocol, so the pairing should be decided before the block starts.

What to Expect

  • Sleep and recovery are noticed early. Reports of better rest arrive in the first weeks, months before body composition shifts.
  • Each shot is a pulse. Growth hormone answers quickly and the signal disappears, which is why injections are daily.
  • Physical change takes the full block. Composition effects accumulate across the 12 to 16 weeks vendors describe.
  • The human half-life is unknown. Six minutes came from rats, 10 to 20 minutes from vendor text, and no settled human figure exists.
  • The human dose is unconfirmed. Amounts circulating for sport are vendor figures, not reviewed clinical data.
  • Class effects include fluid. Oedema, joint discomfort and injection site reactions are described for growth hormone peptides generally.
  • The rules are clear. GHRH and its analogues sit in class S2, with sermorelin named directly.

Side Effects and Management

There is little to manage beyond the ordinary reactions of injected growth hormone peptides, and almost nothing reported as specific to this fragment.

Injection site reactionsRotate the site and keep the technique clean; the most common complaint with daily shots.
Fluid retention and oedemaLower the amount. A class feature of growth hormone peptides.
Joint and muscle painReduce the amount or pause the block. Dose-dependent across the group.
Flushing and headacheSmaller amounts and a bedtime injection usually reduce it. Uncommon.
FatigueAdjust the amount and protect sleep, since sleep quality is the main intended change.
Thin safety data on long pairingsLittle is published on running a GHRH and a ghrelin peptide together for months, so caution is warranted.

Post-Cycle Therapy and Between-Block Breaks

A SERM-based protocol has no function here, because nothing in this peptide suppresses the gonadal axis. Instead, the block itself has an end, and the gap after it is the part worth planning.

OnsetNot applicable: this is a GHRH fragment, not a suppressive steroid
Option ANot applicable
Option BNot applicable
Between blocksVendors advise a four to six week gap after 12-16 weeks of use
Follow-upSleep and general condition; IGF-1 and glucose are the sensible checks on longer runs

Store the powder cold and protected from light, and refrigerate the mixed solution without ever freezing it. The exact post-mix lifespan of these vials has not been verified by the vendor.

This material is published for educational and research reference purposes only. The compounds described are research-grade materials supplied for laboratory work and are not presented here as medicines or as a treatment for any condition. Dosing information reflects published clinical and reference data for the active substances, not a recommendation or a prescription. Nothing on this page should be read as medical advice. Keep all products out of reach of children and follow the regulations that apply in your country.
What is sermorelin, and what does the GHRH(1-29) name mean?
It is the first 29 residues of growth hormone releasing hormone, which is what GHRH(1-29) describes. Instead of supplying growth hormone, it asks the pituitary to release the body's own, in a pulse. Only the powder sold for research remains; the pharmacy version was withdrawn.
How short is the sermorelin half-life?
Very short, and the exact figure is unsettled. The 6.2 minute number was measured in rats after an intravenous dose of the parent peptide, vendor material quotes 10 to 20 minutes, and no validated human value appears in the sources checked.
What amounts are discussed for sermorelin research?
Vendor material grades it from a base figure up to 400 or 500 mcg a day, always by injection. Those numbers are vendor convention rather than a confirmed human dose, and nothing in the sources separates a female schedule.
How is the 2 mg, 5 mg or 10 mg vial reconstituted?
Add bacteriostatic water down the vial wall without shaking. One millilitre in the 5 mg vial gives 5 mg per millilitre and two millilitres gives 2.5 mg per millilitre; the 2 mg vial at 1 ml and the 10 mg vial at 4 ml reach that same 2.5 mg per millilitre strength.
How does sermorelin differ from ipamorelin?
They use different receptors. Sermorelin works on the GHRH receptor, ipamorelin on the ghrelin receptor, so combining them is a pairing rather than a duplication. Ipamorelin also survives about two hours in the body, far longer than this fragment.
How long should a sermorelin block run?
Vendor material describes 12 to 16 weeks followed by a four to six week break. Nothing peer-reviewed fixes those numbers, and the reasoning behind the pause is recovery of the natural pulse pattern rather than any drug clearance.
Which side effects appear with sermorelin?
Reactions where the injection is given, fluid retention, joint and muscle discomfort, occasional flushing, headache and fatigue. All are described for growth hormone peptides as a group; safety data on long pairings with a ghrelin peptide is thin.
Is sermorelin on the prohibited list?
Yes. Class S2 covers growth hormone releasing hormone and its analogues, with sermorelin named directly, and it applies at all times rather than only in competition.

No reviews yet

Be the first to share your experience with Sermorelin 2-10 mg Vials - Generic Peptides

Log in to write a review
Sermorelin 2-10 mg Vials - Generic Peptides
2 mg · International

Complete the protocol

Stack it with

View all →
Added to cart